Other
Lessee Operating Lease Liability Undiscounted Excess Amount
West Pharmaceutical Services Lessee Operating Lease Liability Undiscounted Excess Amount increased by 124.2% to $26.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 105.3%, from $13.10M to $26.90M. Over 3 years (FY 2020 to FY 2023), Lessee Operating Lease Liability Undiscounted Excess Amount shows relatively stable performance with a 2.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2026
How to read this metric
Changes reflect shifts in the discount rates applied to lease liabilities or changes in the duration of the lease portfolio.
Detailed definition
This represents the difference between the total undiscounted future lease payments and the present value of those payme...
Peer comparison
Comparable across firms with significant real estate or equipment lease portfolios under GAAP.
Metric ID:
other_lessee_operating_lease_liability_undiscounted_exce_ce7a69Historical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.30M | $12.60M | $14.10M | $15.00M | $14.70M | $13.90M | $17.70M | $17.10M | $16.40M | $16.00M | $15.90M | $15.30M | $15.00M | $14.20M | $13.10M | $12.80M | $12.00M | $26.90M |
| QoQ Change | — | -5.3% | +11.9% | +6.4% | -2.0% | -5.4% | +27.3% | -3.4% | -4.1% | -2.4% | -0.6% | -3.8% | -2.0% | -5.3% | -7.7% | -2.3% | -6.3% | +124.2% |
| YoY Change | — | — | — | — | +10.5% | +10.3% | +25.5% | +14.0% | +11.6% | +15.1% | -10.2% | -10.5% | -8.5% | -11.3% | -14.4% | -14.7% | -15.5% | +105.3% |
Range$12.00M – $26.90M
CAGR+18.0%
Avg YoY Growth+7.7%
Median YoY Growth+0.9%
Lessee Operating Lease Liability Undiscounted Excess Amount at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's lessee operating lease liability undiscounted excess amount?
- West Pharmaceutical Services (WST) reported lessee operating lease liability undiscounted excess amount of $26.90M in Q1 2026.
- How has West Pharmaceutical Services's lessee operating lease liability undiscounted excess amount changed year-over-year?
- West Pharmaceutical Services's lessee operating lease liability undiscounted excess amount increased by 105.3% year-over-year, from $13.10M to $26.90M.
- What is the long-term trend for West Pharmaceutical Services's lessee operating lease liability undiscounted excess amount?
- Over 3 years (2020 to 2023), West Pharmaceutical Services's lessee operating lease liability undiscounted excess amount has grown at a 2.7% compound annual growth rate (CAGR), from $14.70M to $15.90M.
- What does lessee operating lease liability undiscounted excess amount mean?
- The difference between the total future lease payments and the present value of those payments on the balance sheet.